Abstract
The Canadian Institutes of Health Research (CIHR) has recently developed a major strategic initiative in the areas of regenerative medicine and nanomedicine. The present article presents a preliminary analysis of nanomedicine funding at CIHR (2000-2005), using a moderately stringent definition of nanomedicine.
This is a preview of subscription content, log in via an institution to check access.
Preview
Unable to display preview. Download preview PDF.
References
Canadian Institutes of Health Research (June, 2003); http://www.cihr-irsc.gc.ca/e/16044.html
Canadian Institutes of Health Research (June, 2005); http://www.cihr-irsc.gc.ca/e/28268.html
Canadian Institutes of Health Research (January, 2006); http://www.cihr-irsc.gc.ca/e/29542.html Stem Cell Network (January, 2006); http://www.stemcellnet.ca/
Stem Cell Network (January, 2006); http://www.stemcellnet.ca/e/
Quirion, R., 2002, A Canadian experiment: INMHA. How to link up the brain via a virtual institute, Trends in Neuroscience, 25: 268-270.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2006 Springer
About this paper
Cite this paper
MARCOTTE, E., QUIRION, R. (2006). A SUMMARY OF CANADIAN NANOMEDICINE RESEARCH FUNDING: STRENGTHS AND NEEDS. In: Dubowski, J.J., Tanev, S. (eds) Photon-based Nanoscience and Nanobiotechnology. NATO Science Series, vol 239. Springer, Dordrecht. https://doi.org/10.1007/978-1-4020-5523-2_15
Download citation
DOI: https://doi.org/10.1007/978-1-4020-5523-2_15
Publisher Name: Springer, Dordrecht
Print ISBN: 978-1-4020-5521-8
Online ISBN: 978-1-4020-5523-2
eBook Packages: Chemistry and Materials ScienceChemistry and Material Science (R0)